NON-INVASIVE MARKERS ASSOCIATED WITH LIVER FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE
- Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation. Brunt, Elizabeth M. // International Journal of Molecular Sciences;2016, Vol. 17 Issue 1, p1
The diagnostic phenotype of nonalcoholic fatty liver disease (NAFLD)â€”in particular, the most significant form in terms of prognosis, nonalcoholic steatohepatitis (NASH)â€”continues to rely on liver tissue evaluation, in spite of remarkable advances in non-invasive algorithms...
- Non-alcoholic fatty liver disease: what's new under the microscope? Brunt, Elizabeth M. // Gut;Aug2011, Vol. 60 Issue 8, p1152
Pathologist's observations have remained central to the evolution of the field of non-alcoholic fatty liver disease, even with the advent of increasingly effective non-invasive markers of advanced fibrosis. As the field matures, the role of pathology has also shifted from being largely...
- Is transient elastography a useful tool for screening liver disease? Del Poggio, Paolo; Colombo, Silvia; Castellote, Jose // World Journal of Gastroenterology;3/28/2009, Vol. 15 Issue 12, p1409
Transient elastography (TE) is a new non invasive tool for measuring liver stiffness, which is correlated to the histologic stage of liver fibrosis. Several studies in chronic liver disease (CLD) have determined a good accuracy of TE in predicting significant fibrosis and an optimal accuracy in...
- Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients. Durango, Esteban; Dietrich, Christian; Seitz, Helmut Karl; Kunz, Cornelia Ursula; Pomier-Layrargues, Gilles T.; Duarte-Rojo, Andres; Beaton, Melanie; Elkhashab, Magdy; Myers, Robert P.; Mueller, Sebastian // Hepatic Medicine: Evidence & Research;2013, Vol. 5, p43
Background: A novel Fibroscan XL probe has recently been introduced and validated for obese patients, and has a diagnostic accuracy comparable with that of the standard M probe. The aim of this study was to analyze and understand the differences between these two probes in nonobese patients, to...
- Liver Stiffness Measurements in Patients with Different Stages of Nonalcoholic Fatty Liver Disease: Diagnostic Performance and Clinicopathological Correlation. Kumar, Ramesh; Rastogi, Archana; Sharma, Manoj; Bhatia, Vikram; Tyagi, Pankaj; Sharma, Praveen; Garg, Hitendra; Chandan Kumar, K.; Bihari, Chhagan; Sarin, Shiv // Digestive Diseases & Sciences;Jan2013, Vol. 58 Issue 1, p265
Background: The present study evaluated performance characteristics of liver stiffness measurement (LSM) by FibroScan in patients with different stages of nonalcoholic fatty liver disease (NAFLD). Patients and Methods: A total of 307 subjects (120 NAFLD, 85 NAFLD related cirrhosis, and 102...
- Rupture of the Liver Associated with Acute Fatty Liver of Pregnancy. Minuk, G. Y.; Kelly, J. K.; Lui, R. C. // American Journal of Gastroenterology;May1987, Vol. 82 Issue 5, p457
Describes a case of a patient with rupture of the liver associated with acute fatty liver during pregnancy. Disease symptoms observed on the patient; Maternal blood pressure of the patient before surgery; Pathological description of the biopsy obtained from the liver of the patient.
- Corrections. // Gut;Aug2015, Vol. 64 Issue 8, p1337
A correction to the article "Pathobiology of Liver Fibrosis - A Translational Success Story" by Y. A. Lee that was published in a 2015 issue of the periodical is presented.
- Corrections. // Gut;Aug2015, Vol. 64 Issue 8, p137
A correction to the article "Pathobiology of Liver Fibrosis Ã¢â‚¬ A Translational Success Story" by Y. A. Lee that was published in a 2015 issue of the periodical is presented.
- Assessment of Liver Fibrosis: Noninvasive Means. Poynard, Thierry; Morra, Rachel; Ingiliz, Patrick; Imbert-Bismut, Françoise; Thabut, Dominique; Messous, Djamila; Munteanu, Mona; Massard, Julien; Benhamou, Yves; Ratziu, Vlad // Saudi Journal of Gastroenterology;Oct2008, Vol. 14 Issue 4, p163
Liver biopsy, owing to its limitations and risks, is an imperfect gold standard for assessing the severity of the most frequent chronic liver diseases chronic hepatitis C (HCV), B (HBV) non alcoholic (NAFLD) and alcoholic (ALD) fatty liver diseases. This review summarizes the advantages and the...